Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 238

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy

Open access
Mahadeo, Kris M., Khazal, Sajad J., Abdel-Azim, Hisham, Fitzgerald, Julie C., Taraseviciute, Agne, Bollard, Catherine M., Tewari, Priti, Duncan, Christine, Traube, Chani, McCall, David, Steiner, Marie E., Cheifetz, Ira M., Lehmann, Leslie E., Mejia, Rodrigo, Slopis, John M., Bajwa, Rajinder, Kebriaei, Partow, Martin, Paul L., Moffet, Jerelyn, McArthur, Jennifer, Petropoulos, Demetrios, O’Hanlon Curry, Joan, Featherston, Sarah, Foglesong, Jessica, Shoberu, Basirat, Gulbis, Alison, Mireles, Maria E., Hafemeister, Lisa, Nguyen, Cathy, Kapoor, Neena, Rezvani, Katayoun, Neelapu, Sattva S., Shpall, Elizabeth J., the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network · 2019 · Nature Reviews Clinical Oncology

Abstract

In 2017, an autologous chimeric antigen receptor (CAR) T cell therapy indicated for children and young adults with relapsed and/or refractory CD19+ acute lymphoblastic leukaemia became the first gene therapy to be approved in the USA. This innovative form of cellular immunotherapy has been associated with remarkable response rates but is also associated with unique and often severe toxicities, which can lead to rapid cardiorespiratory and/or neurological deterioration. Multidisciplinary medical vigilance and the requisite health-care infrastructure are imperative to ensuring optimal patient outcomes, especially as these therapies transition from research protocols to standard care. Herein, authors representing the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Hematopoietic Stem Cell Transplantation (HSCT) Subgroup and the MD Anderson Cancer Center CAR T Cell Therapy-Associated Toxicity (CARTOX) Program have collaborated to provide comprehensive consensus guidelines on the care of children receiving CAR T cell therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41571-018-0075-2

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 238

Metadata

Authors
Mahadeo, K. M., Khazal, S. J., Abdel-Azim, H., Fitzgerald, J. C., Taraseviciute, A., Bollard, C. M., Tewari, P., Duncan, C., Traube, C., McCall, D., Steiner, M. E., Cheifetz, I. M., Lehmann, L. E., Mejia, R., Slopis, J. M., Bajwa, R., Kebriaei, P., Martin, P. L., Moffet, J., McArthur, J., Petropoulos, D., O’Hanlon Curry, J., Featherston, S., Foglesong, J., Shoberu, B., Gulbis, A., Mireles, M. E., Hafemeister, L., Nguyen, C., Kapoor, N., Rezvani, K., Neelapu, S. S., Shpall, E. J., & the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Venue
Nature Reviews Clinical Oncology
Published
2018-08-06
Volume
16
Issue
1
Pages
45-63
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2885496269
Cited by
238
References
22
FWCI
3.96
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. https://app.cochat.ai/papers/10.1038/s41571-018-0075-2
The paper
Mahadeo, K. M., Khazal, S. J., Abdel-Azim, H., Fitzgerald, J. C., Taraseviciute, A., Bollard, C. M., Tewari, P., Duncan, C., Traube, C., McCall, D., Steiner, M. E., Cheifetz, I. M., Lehmann, L. E., Mejia, R., Slopis, J. M., Bajwa, R., Kebriaei, P., Martin, P. L., Moffet, J., . . . the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. (2019). Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-018-0075-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.